User profiles for Marisa Holubar

Marisa Holubar, MD MS

Clinical Associate Professor, Stanford University of School of Medicine
Verified email at stanford.edu
Cited by 1741

Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity

…, SD Boyd, MM Davis, M Holubar… - Science Translational …, 2022 - science.org
A damaging inflammatory response is implicated in the pathogenesis of severe coronavirus
disease 2019 (COVID-19), but mechanisms contributing to this response are unclear. In two …

Comprehensive guidance for antibiotic dosing in obese adults

L Meng, E Mui, MK Holubar… - … : The Journal of Human …, 2017 - Wiley Online Library
Physiologic alterations seen in obesity commonly impact the pharmacokinetics (PK) and
pharmacodynamics (PD) of antibiotics and may result in suboptimal dosing in this expanding …

Association of race/ethnicity with likeliness of COVID-19 vaccine uptake among health workers and the general population in the San Francisco Bay Area

…, C Lindan, SB Doernberg, M Holubar - JAMA internal …, 2021 - jamanetwork.com
Letters jamainternalmedicine. com(Reprinted) JAMA Internal Medicine July 2021 Volume
181, Number 7 1009 dents, 0.28 (0.15-0.53) for respondents of other races, and 0.49 (0.29-…

Antimicrobial Resistance in Methicillin-Resistant Staphylococcus aureus to Newer Antimicrobial Agents

RR Watkins, M Holubar, MZ David - Antimicrobial agents and …, 2019 - Am Soc Microbiol
Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) result in significant
morbidity and mortality for patients in both community and health care settings. This is …

Conversion from vancomycin trough concentration–guided dosing to area under the curve–guided dosing using two sample measurements in adults: implementation …

…, G Espinosa, J Desai, M Holubar… - … : The Journal of …, 2019 - Wiley Online Library
Study Objective The optimal pharmacodynamic parameter for the prediction of efficacy of
vancomycin is the area under the concentration–time curve (AUC), and current published data …

Cefiderocol: a new cephalosporin stratagem against multidrug-resistant Gram-negative bacteria

…, M Czech, E Robilotti, M Holubar - Clinical Infectious …, 2022 - academic.oup.com
Cefiderocol is a novel injectable siderophore cephalosporin that hijacks the bacterial iron
transport machinery to facilitate cell entry and achieve high periplasmic concentrations. It has …

Real-time electronic tracking of diarrheal episodes and laxative therapy enables verification of Clostridium difficile clinical testing criteria and reduction of Clostridium …

…, G Sundararajan, N Tekic, M Holubar… - Journal of clinical …, 2017 - Am Soc Microbiol
Health care-onset health care facility-associated Clostridium difficile infection (HO-CDI) is
overdiagnosed for several reasons, including the high prevalence of C. difficile colonization …

Antimicrobial resistance in sexually transmitted infections

V Tien, C Punjabi, MK Holubar - Journal of travel medicine, 2020 - academic.oup.com
Rationale for review International travel facilitates the spread of drug-resistant infections,
including sexually transmitted infections (STIs). In 2016, the World Health Organization …

Oral fluoroquinolone or trimethoprim-sulfamethoxazole vs ß-lactams as step-down therapy for Enterobacteriaceae bacteremia: systematic review and meta-analysis

…, L Meng, S Deresinski, M Holubar - Open Forum …, 2019 - academic.oup.com
Background Using published data, we sought to compare outcomes in patients transitioned
to either oral fluoroquinolones (FQs) or trimethoprim-sulfamethoxazole (TMP-SMX) vs ß-…

The E7 Oncoprotein of Human Papillomavirus Type 16 Stabilizes p53 through a Mechanism Independent of p19ARF

SE Seavey, M Holubar, LJ Saucedo… - Journal of virology, 1999 - Am Soc Microbiol
High-risk human papillomaviruses are causally associated with cervical cancer. Two viral
oncogenes, E6 and E7, are expressed in most cervical cancers, and these genes cause …